The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Aker Hazel M since 2011.
The trader's CIK number is 1265783.
At the time of the last reporting, Aker Hazel M was the SVP, GC & Secretary of Oncternal Therapeutics, Inc.. (stock ticker symbol ONCT).
Also see all insider trading activities at Oncternal Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2020 | ONCT | 41,972 | $100,019 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2013 | CADX | 0 | $0 | 78,085 | $598,076 | 78,085 | $274,077 |
| 2011 | CADX | 0 | $0 | 10,000 | $41,620 | 10,000 | $0 |
1. Oncternal Therapeutics, Inc. (ONCT)
2. Cadence Pharmaceuticals Inc (CADX)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2020-07-21 | ONCT | Buy | 41,972 | 2.38 | 100,019 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2013-12-16 | CADX | Sale | 13,014 | 8.76 | 114,002 |
| 2013-12-16 | CADX | Option Ex | 13,014 | 3.51 | 45,679 |
| 2013-11-15 | CADX | Option Ex | 52,056 | 3.51 | 182,716 |
| 2013-11-15 | CADX | Sale | 52,056 | 7.41 | 385,474 |
| 2013-07-22 | CADX | Option Ex | 6,507 | 3.51 | 22,839 |
| 2013-07-22 | CADX | Sale | 6,507 | 7.81 | 50,819 |
| 2013-07-15 | CADX | Option Ex | 6,508 | 3.51 | 22,843 |
| 2013-07-15 | CADX | Sale | 6,508 | 7.34 | 47,781 |
| 2011-11-21 | CADX | Sale | 10,000 | 4.16 | 41,620 |
| 2011-11-02 | CADX | Option Ex | 10,000 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Aker Hazel M (SVP, GC & Secretary of Oncternal Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.